Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Breast Care (Basel, Switzerland)|November 1, 2021
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer PatientsRudolf Napieralski, Gabriele Schricker, Gert Auer, et al.
The Journal of Investigative Dermatology|December 30, 2006
The alpha and beta subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiationChristoph Becker-Pauly, Markus Höwel, Tatjana Walker, et al.
Thrombosis and Haemostasis|April 21, 2005
Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1Buddy Setyono-Han, Jörg Stürzebecher, Wolfgang A Schmalix, et al.
Biological Chemistry|July 30, 2017
Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancerFeng Yang, Michaela Aubele, Axel Walch, et al.
Cancers|August 27, 2021
Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal AdenocarcinomaJuliana B Candido, Oscar Maiques, Melanie Boxberg, et al.
Contrast Media & Molecular Imaging|August 26, 2016
Preclinical evaluation of [111 In]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activityChristel Vangestel, David Thomae, Jeroen Van Soom, et al.
Molecular & Cellular Proteomics : MCP|February 2, 2019
Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell SecretomeLakmali Munasinghage Silva, Thomas Kryza, Thomas Stoll, et al.
Biochemical and Biophysical Research Communications|February 2, 2016
The solution structure of the kallikrein-related peptidases inhibitor SPINK6Sascha Jung, Jan Fischer, Björn Spudy, et al.
Molecular Oncology|February 19, 2026
Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high-grade serous ovarian cancerSophia Bielesch, Isabel Vogel, Sina Nokodian, et al.
European Journal of Medicinal Chemistry|May 31, 2022
Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitorsOliver Pilgram, Aline Keils, Gerrit E Benary, et al.
Pageof 13